跳至主要内容
临床试验/NCT06158932
NCT06158932已完成不适用

A Single Group Study to Evaluate the Effects of a Myo-Inositol and D-Chiro Inositol Supplement on Symptoms Associated With Polycystic Ovary Syndrome and Hormone Imbalance

Optify2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年9月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
2
主要终点
Changes in menstrual cycle regularity. [Timeframe: Baseline to Week 12]

研究概览

简要总结

This is a virtual single group study that will last 12 weeks. 40 female participants will take 4 capsules of the Optify Myo Inositol and D-Chiro Inositol Plus Folate and Vitamin D supplement per day. Questionnaires will be completed at Baseline, Week 4, Week 8 and Week 12. Participants will also provide a waist circumference measurement at Baseline and Week 12.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged between 18 - 55
  • BMI less than 35
  • Self-reported symptoms of PCOS like irregular periods, excessive hair growth, weight gain, oily skin, or acne
  • Self-reported concerns around irregular menstrual cycles and ovulation, mood swings, stress, irritability, and low energy
  • Self-reported concerns with hormonal skin issues
  • Has access to a tape measure for waist measurement
  • Generally healthy - don't live with any uncontrolled chronic disease

排除标准

  • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
  • Anyone with known severe allergic reactions
  • Anyone who is pregnant or breastfeeding
  • Unwilling to follow the study protocol

结局指标

主要结局

Changes in menstrual cycle regularity. [Timeframe: Baseline to Week 12]

时间窗: 12 weeks

Measured via study-specific questionnaires with participants reporting menstrual cycle occurrence and regularity during the trial.

Changes in hormonal skin issues. [Timeframe: Baseline to Week 12]

时间窗: 12 weeks

Measured via study-specific questionnaires using a 5-point Likert scale. A lower score indicates a more favourable response, with 0=Not noticeable and 4=Severe.

Changes in excessive body hair or facial hair. [Timeframe: Baseline to Week 12]

时间窗: 12 weeks

Measured via study-specific questionnaires using a 5-point Likert scale. A lower score indicates a more favourable response, with 0=Not noticeable and 4=Severe.

Changes in severity of menstrual cramps. [Timeframe: Baseline to Week 12]

时间窗: 12 weeks

Measured via study-specific questionnaires using a 5-point Likert scale. A lower score indicates a more favourable response, with 0=Not noticeable and 4=Severe.

次要结局

  • Changes in sleep quality. [Timeframe: Baseline to Week 12](12 weeks)
  • Changes in energy. [Timeframe: Baseline to Week 12](12 weeks)
  • Changes in mood. [Timeframe: Baseline to Week 12](12 weeks)
  • Changes in stress. [Timeframe: Baseline to Week 12](12 weeks)
  • Changes in food cravings. [Timeframe: Baseline to Week 12](12 weeks)

研究者

发起方
Optify
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验